Skip to main content

Peer Review reports

From: Switch to aflibercept or ranibizumab after initial treatment with bevacizumab in eyes with neovascular AMD

Original Submission
14 Feb 2017 Submitted Original manuscript
23 Mar 2017 Reviewed Reviewer Report - Hemant Khanna
25 Mar 2017 Reviewed Reviewer Report - Ceyhun Arici
25 Apr 2017 Author responded Author comments - Maria Waizel
Resubmission - Version 2
25 Apr 2017 Submitted Manuscript version 2
9 May 2017 Author responded Author comments - Maria Waizel
Resubmission - Version 3
9 May 2017 Submitted Manuscript version 3
Publishing
15 May 2017 Editorially accepted
23 May 2017 Article published 10.1186/s12886-017-0471-x

You can find further information about peer review here.

Back to article page